相关实验视频

Updated: Jun 12, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

对与疾病相关的PLCγ2变异分子机制的表征

Tom D Bunney¹, Charis Kampyli¹, Ashley Gregory¹

¹Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, UK.

Advances in biological regulation

|September 23, 2024

概括

脂酶C玛2 (PLCγ2) 突变会影响免疫系统疾病和癌症. P522R变体通过微妙地改变蛋白质相互作用,而不会直接影响PLC活性,从而提供阿尔茨海默病的保护.

科学领域:

生物化学生物化学
分子生物学分子生物学
神经科学是一个神经科学.

背景情况:

脂酶C玛2 (PLCγ2) 在免疫细胞调节中至关重要,并与免疫疾病和癌症耐药性有关.
PLCγ2中的突变与各种疾病有关,包括慢性淋巴细胞白血病对ibrutinib的耐药性.
一种罕见的PLCγ2变体,P522R,已经证明在阿尔茨海默病 (AD) 中起着保护作用.

研究的目的:

综合分析和比较与疾病相关的PLCγ2突变 (M1141K) 和AD保护变体 (P522R) 的分子机制.
了解这些变体在它们的活性和细胞功能上有什么不同,有助于治疗的发展.

主要方法:

使用体外生化试验和基于细胞的试验对PLCγ2 M1141K和P522R变体进行比较分析.
用PLCγ酶的结构见解来进行变异分析.
生成和分析表达PLCγ2变异的稳定微质细胞 (BV2) 细胞系.

主要成果:

在细胞和体外试验中,PLCγ2 M1141K突变显示出显著增强的活性,与免疫障碍和癌症相关突变一致.
在PLCγ2 P522R变体的基底PLC活性在体外与野生类型 (WT) 没有显著差异,但通过Btk.显示增强酸化.
在微质细胞中,与WT相比,PLCγ2 P522R表达导致了增强的PLC活性和改变的细胞形态.

结论:

PLCγ2 M1141K变种表现出强烈的激活,与P522R变种不同,表明不同的作用机制.
保护AD的P522R变体可能通过微妙的结构变化来起作用,调节与其他蛋白质的相互作用,而不是直接改变PLC活动.
P522R的功能影响取决于细胞环境和与激酶和调节蛋白的相互作用,为AD提供潜在的治疗途径.

关键词:

与疾病相关的变体免疫系统疾病免疫系统疾病分子机制的分子机制神经退行发生神经退行.脂酶C玛2的使用

更多相关视频

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

相关概念视频

IP3/DAG Signaling Pathway

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...

Covalently Linked Protein Regulators

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....

Amplifying Signals via Enzymatic Cascade

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...